PharmEng Technology
PharmEng Technology is a privately held Canadian life-sciences consulting firm founded in 1997, providing CQV, validation, quality, regulatory affairs, engineering, toxicology, and training services to pharmaceutical, biotechnology, and medical device companies; since January 2025 it operates as part of the Efor Group, serving enterprise clients across 12 countries.
- Company typePrivate
- Founded1997
- HeadquartersToronto, Canada
- Headcount101–250
- GTM typeB2B
- OfferingServices
What PharmEng Technology does
PharmEng Technology is a privately held Canadian life-sciences consulting firm founded in 1997 in Toronto by Alan Kwong, providing project-based consulting services to pharmaceutical, biotechnology, medical device, and nutraceutical companies across the full product lifecycle. Core service lines include Commissioning and Qualification, Validation, Quality Services, Regulatory Affairs, Engineering, Project Management, Thermal Mapping, Toxicology, Training, Technical Writing, and Automation Engineering Solutions. The firm employs certified subject matter experts (PMP, ASQ-CQA, Lean Six Sigma, RAC, board-certified toxicologists) and delivers under ISO 9001:2015 ANAB-certified quality management, with validation deliverables described as accepted by FDA and Health Canada.
The business operates on a direct enterprise consulting model with quote-based, multi-year project engagements and a 100% direct-to-client channel. As of January 2025, PharmEng joined the Efor Group, a European life-sciences consulting platform, forming a combined entity of approximately 2,800 employees across 12 countries with €240 million in reported 2024 revenue. The combined firm now operates 14+ offices across Canada, the United States, Singapore, Indonesia, Malaysia, Taiwan, Denmark, Ireland, Spain, Brazil, the Dominican Republic, and Puerto Rico, with named enterprise customers including AbbVie, Alcon, Sanofi, Takeda, and United Therapeutics.
Technology offerings include the proprietary AT-Log Sensing System (launched October 2024), a cloud-based LoRaWAN wireless environmental monitoring platform, and AI/ML capabilities integrated into CQV workflows including predictive maintenance, anomaly detection, and Explainable AI (XAI) methods (SHAP, LIME) for regulatory-grade accountability. Integration partnerships span six MES platforms (Syncade, PAS-X, Aspentech, Pharmasuite, LZ Lifescience, POMSnet), supporting vendor-agnostic automation engineering services for pharmaceutical manufacturing clients.
PharmEng Technology firmographics
Firmographics- Name
- PharmEng Technology
- Legal name
- PharmEng Technology
- Website
- https://pharmeng.com
- Company type
- Private
- Founded year
- 1997
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- PharmEng Technology is a privately held Canadian life-sciences consulting firm founded in 1997, providing CQV, validation, quality, regulatory affairs, engineering, toxicology, and training services to pharmaceutical, biotechnology, and medical device companies; since January 2025 it operates as part of the Efor Group, serving enterprise clients across 12 countries.
- Ownership category
- akta.pro rank
Where PharmEng Technology is headquartered
LocationHeadquarters
- HQ city
- Toronto
- HQ country
- Canada
- HQ region
- North America
Offices15 records
Markets served
PharmEng Technology business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D
Revenue model
- Pharmaceutical Consulting Services: Professional consulting services provided to pharmaceutical, biotechnology, medical device, and nutraceutical industries. Services include Commissioning & Qualification, Validation, Quality Systems, Regulatory Affairs, Engineering, Training, Toxicology, Thermal Mapping, Technical Writing, Project Management, and Automation Engineering Solutions. Revenue is generated through project-based consulting engagements with subject matter experts.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | Custom Project-Based Consulting |
Go-to-market motion1 record
Distribution channels1 record
Marketing channels5 records
PharmEng Technology product offering
Product offeringCore offering
PharmEng Technology provides consulting services to pharmaceutical, biotech, and medical device companies. Their service portfolio spans commissioning and qualification, validation, engineering, project management, quality systems, regulatory affairs, thermal mapping, toxicology, training, technical writing, and automation engineering solutions for regulated life-sciences manufacturers.
Product overview
PharmEng Technology is a global full-service consulting firm serving pharmaceutical, biotechnology, medical device, and nutraceutical industries. The company offers an integrated portfolio of consulting services organized around lifecycle stages: from regulatory affairs and pharmaceutical consulting in early development, through engineering and automation for facility/process design, to commissioning & qualification, validation, and quality services for manufacturing compliance. Core service modules include Technical Writing, Toxicology, Thermal Mapping, Project Management, and Training. The AT-Log Sensing System represents a proprietary product offering for environmental monitoring. Services are delivered through over 3,000 experts across 12 countries following the company's 2025 integration with the Efor Group.
Differentiator
Problem solved
Functional benefit
Products and services
- Commissioning and Qualification
- Validation
- Engineering
- Project Management
- Quality Services
- Regulatory Affairs
- Thermal Mapping
- Toxicology
- Training
- Technical Writing
- Automation Engineering Solutions
- AT-Log Sensing System
Companies that use PharmEng Technology
Customer profileNamed customers7 records
Segments4 records
Ideal customer profiles1 record
PharmEng Technology technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration6 records
AI capability4 records
Feature4 records
PharmEng Technology partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Efor GroupflagshipIn January 2025, PharmEng Technology joined the Efor Group in a transformative strategic partnership. The Efor Group, founded in 2013, is a European leader in life sciences consulting with over 2,500 employees across France, Belgium, Switzerland, and the United States. The combined entity now operates with 2,800 employees across 12 countries. This partnership enables PharmEng to expand global reach while offering integrated solutions spanning the entire lifecycle of healthcare products from R&D to market launch and post-market vigilance.
Scale indicators6 records
Recent moves6 records
Expansion highlights6 records
PharmEng Technology competitors and assessment
Company assessmentDirect peers
- Kymanox: US-based life sciences consulting firm providing regulatory affairs, quality, validation, and process engineering services to pharma, biotech, and medical device manufacturers — overlapping service portfolio and target customer base with PharmEng.
- Commissioning Agents Inc (CAI): US-based firm specializing in commissioning, qualification, validation, and regulatory services for pharmaceutical, biotech, and medical device manufacturers — directly comparable to PharmEng's core C&Q/validation business.
- NNE Pharmaplan: Novo Nordisk-owned engineering consultancy specializing in pharma facility design, process engineering, commissioning/qualification, and validation — directly comparable to PharmEng's CQV and engineering services for the same enterprise pharma/biotech buyers.
- Trinity Consultants (ADVENT Engineering division): ADVENT Engineering Services, a Trinity Consultants life sciences division (where PharmEng EVP Dharti Pancholi previously served as COO), provides pharma engineering, validation, and regulatory consulting — directly overlapping with PharmEng's service lines and target market.
- ProPharma Group: Global regulatory, compliance, and quality consulting firm for life sciences companies; offers regulatory affairs, validation, and pharmacovigilance consulting — directly comparable to PharmEng's quality and regulatory service lines.
- Efor Group: PharmEng's parent/strategic partner since January 2025; Efor is a European life sciences consulting firm with 2,800+ employees across 12 countries offering validation, regulatory affairs, quality, and toxicology services — a near-perfect direct peer with overlapping service lines and target customers.
- PharmaLex: Specialist regulatory affairs and pharmacovigilance consulting firm serving pharma and biotech globally; strong overlap with PharmEng's regulatory affairs, quality, and toxicology services and similar enterprise customer profile.
Emerging players
- Atlantic Technical Group: Niche consulting firm providing commissioning, qualification, validation, and metrology services to pharma and biotech manufacturers — a smaller, more specialized peer competing for similar CQV engagements.
Broad incumbents
- ICON plc: Global CRO and consulting services firm serving pharma/biotech; while primarily a clinical CRO, ICON's consulting and bioanalytical labs overlap with parts of PharmEng's quality and validation offerings for large enterprise pharma clients.
- Certara: Large publicly-traded biosimulation and regulatory science consulting firm serving the broader life sciences industry; while Certara is broader and tech-enabled, it competes for the same regulatory affairs and drug development consulting mandates from large pharma.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat6 records
Key risks6 records
Key highlights7 records
Customer concentration
PharmEng Technology social profiles
Digital presencePharmEng Technology compliance and trust
Trust signalCompliance1 record
PharmEng Technology financial estimates
Financial estimateRevenue estimate
Valuation estimate
PharmEng Technology leadership team
Management profileNumber of profiles
Profiles1 record
PharmEng Technology subsidiaries and ownership
Company hierarchySubsidiaries1 record
PharmEng Technology funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
PharmEng Technology M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about PharmEng Technology
What does PharmEng Technology do?
PharmEng Technology provides consulting services to pharmaceutical, biotech, and medical device companies. Their service portfolio spans commissioning and qualification, validation, engineering, project management, quality systems, regulatory affairs, thermal mapping, toxicology, training, technical writing, and automation engineering solutions for regulated life-sciences manufacturers.
Is PharmEng Technology a public or private company?
PharmEng Technology is a private company. It is classified as corporate owned and is currently operating.
When was PharmEng Technology founded?
PharmEng Technology was founded in 1997. It employs 101 to 250 people.
Where is PharmEng Technology based?
PharmEng Technology is headquartered in Toronto, Canada, in the North America region.
How does PharmEng Technology make money?
One revenue line is on record: pharmaceutical Consulting Services.
Who are PharmEng Technology's main competitors?
Direct peers on record are Kymanox, Commissioning Agents Inc (CAI), NNE Pharmaplan, Trinity Consultants (ADVENT Engineering division), ProPharma Group, Efor Group and PharmaLex. Atlantic Technical Group is listed as an emerging player. Broad incumbents are ICON plc and Certara.
Does PharmEng Technology have an API?
No public API is recorded for PharmEng Technology.